Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium
- PMID: 27023175
- PMCID: PMC4872459
- DOI: 10.1038/tp.2016.36
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium
Abstract
Cannabis is the most widely produced and consumed illicit psychoactive substance worldwide. Occasional cannabis use can progress to frequent use, abuse and dependence with all known adverse physical, psychological and social consequences. Individual differences in cannabis initiation are heritable (40-48%). The International Cannabis Consortium was established with the aim to identify genetic risk variants of cannabis use. We conducted a meta-analysis of genome-wide association data of 13 cohorts (N=32 330) and four replication samples (N=5627). In addition, we performed a gene-based test of association, estimated single-nucleotide polymorphism (SNP)-based heritability and explored the genetic correlation between lifetime cannabis use and cigarette use using LD score regression. No individual SNPs reached genome-wide significance. Nonetheless, gene-based tests identified four genes significantly associated with lifetime cannabis use: NCAM1, CADM2, SCOC and KCNT2. Previous studies reported associations of NCAM1 with cigarette smoking and other substance use, and those of CADM2 with body mass index, processing speed and autism disorders, which are phenotypes previously reported to be associated with cannabis use. Furthermore, we showed that, combined across the genome, all common SNPs explained 13-20% (P<0.001) of the liability of lifetime cannabis use. Finally, there was a strong genetic correlation (rg=0.83; P=1.85 × 10(-8)) between lifetime cannabis use and lifetime cigarette smoking implying that the SNP effect sizes of the two traits are highly correlated. This is the largest meta-analysis of cannabis GWA studies to date, revealing important new insights into the genetic pathways of lifetime cannabis use. Future functional studies should explore the impact of the identified genes on the biological mechanisms of cannabis use.
Figures
Comment in
-
Connecting the dots, genome-wide association studies in substance use.Mol Psychiatry. 2016 Jun;21(6):733-5. doi: 10.1038/mp.2016.14. Epub 2016 Mar 15. Mol Psychiatry. 2016. PMID: 26976040 No abstract available.
Similar articles
-
Short communication: Genetic association between schizophrenia and cannabis use.Drug Alcohol Depend. 2017 Feb 1;171:117-121. doi: 10.1016/j.drugalcdep.2016.09.022. Epub 2017 Jan 10. Drug Alcohol Depend. 2017. PMID: 28086176 Free PMC article.
-
Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.Psychiatry Res. 2022 Apr;310:114453. doi: 10.1016/j.psychres.2022.114453. Epub 2022 Feb 17. Psychiatry Res. 2022. PMID: 35235886
-
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.Nat Neurosci. 2018 Sep;21(9):1161-1170. doi: 10.1038/s41593-018-0206-1. Epub 2018 Aug 27. Nat Neurosci. 2018. PMID: 30150663 Free PMC article.
-
The genetic epidemiology of cannabis use, abuse and dependence.Addiction. 2006 Jun;101(6):801-12. doi: 10.1111/j.1360-0443.2006.01399.x. Addiction. 2006. PMID: 16696624 Review.
-
High genes: Genetic underpinnings of cannabis use phenotypes.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110164. doi: 10.1016/j.pnpbp.2020.110164. Epub 2020 Nov 3. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33152387 Review.
Cited by
-
COLOCdb: a comprehensive resource for multi-model colocalization of complex traits.Nucleic Acids Res. 2024 Jan 5;52(D1):D871-D881. doi: 10.1093/nar/gkad939. Nucleic Acids Res. 2024. PMID: 37941154 Free PMC article.
-
A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.bioRxiv [Preprint]. 2024 Jun 17:2024.04.03.587900. doi: 10.1101/2024.04.03.587900. bioRxiv. 2024. Update in: Elife. 2024 Sep 05;13:RP97150. doi: 10.7554/eLife.97150. PMID: 38617224 Free PMC article. Updated. Preprint.
-
Suicidality risk after using cannabis and cannabinoids: An umbrella review.Dialogues Clin Neurosci. 2023 Dec;25(1):50-63. doi: 10.1080/19585969.2023.2231466. Dialogues Clin Neurosci. 2023. PMID: 37427882 Free PMC article.
-
The genetic landscape of substance use disorders.Mol Psychiatry. 2024 Nov;29(11):3694-3705. doi: 10.1038/s41380-024-02547-z. Epub 2024 May 29. Mol Psychiatry. 2024. PMID: 38811691 Free PMC article. Review.
-
Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice.Front Genet. 2021 Jul 23;12:659012. doi: 10.3389/fgene.2021.659012. eCollection 2021. Front Genet. 2021. PMID: 34367237 Free PMC article.
References
-
- United Nations Office on Drugs and Crime. 2010 World Drug Report, New York, USA, 2010.
-
- Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998; 352: 1611–1616. - PubMed
-
- Hall W, Babor TF. Cannabis use and public health: assessing the burden. Addiction 2000; 95: 485–490. - PubMed
-
- Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD. Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag 2009; 5: 153–168. - PubMed
-
- Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 2014; 110: 19–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA009203/AA/NIAAA NIH HHS/United States
- U01 DA024417/DA/NIDA NIH HHS/United States
- MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom
- R01 AA012502/AA/NIAAA NIH HHS/United States
- R01 DA018673/DA/NIDA NIH HHS/United States
- U01 MH094432/MH/NIMH NIH HHS/United States
- R37 DA005147/DA/NIDA NIH HHS/United States
- R01 DA018660/DA/NIDA NIH HHS/United States
- RC2 MH089951/MH/NIMH NIH HHS/United States
- R01 DA005147/DA/NIDA NIH HHS/United States
- RC2 DA028909/DA/NIDA NIH HHS/United States
- R01 DA036216/DA/NIDA NIH HHS/United States
- K24 DA032555/DA/NIDA NIH HHS/United States
- R37 AA009367/AA/NIAAA NIH HHS/United States
- R01 AA007535/AA/NIAAA NIH HHS/United States
- R01 DA18432/DA/NIDA NIH HHS/United States
- R01 DA035804/DA/NIDA NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- R01 MH081802/MH/NIMH NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- R01 DA012690/DA/NIDA NIH HHS/United States
- N01 HG065403/HG/NHGRI NIH HHS/United States
- R01 AA009367/AA/NIAAA NIH HHS/United States
- R01 AA11330/AA/NIAAA NIH HHS/United States
- RC2 MH089995/MH/NIMH NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- R01 AA007728/AA/NIAAA NIH HHS/United States
- MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom
- R01 DA023668/DA/NIDA NIH HHS/United States
- R01 DA021905/DA/NIDA NIH HHS/United States
- R01 DA021913/DA/NIDA NIH HHS/United States
- R01 HD042157/HD/NICHD NIH HHS/United States
- R01 AA011886/AA/NIAAA NIH HHS/United States
- R01 DA12849/DA/NIDA NIH HHS/United States
- MR/K023195/1/MRC_/Medical Research Council/United Kingdom
- R56 DA012854/DA/NIDA NIH HHS/United States
- R37 DA018673/DA/NIDA NIH HHS/United States
- R01 AA013321/AA/NIAAA NIH HHS/United States
- R01 DA018432/DA/NIDA NIH HHS/United States
- MR/K023233/1/MRC_/Medical Research Council/United Kingdom
- R01 DA024417/DA/NIDA NIH HHS/United States
- R01 DA018267/DA/NIDA NIH HHS/United States
- K02 AA018755/AA/NIAAA NIH HHS/United States
- R01 MH066140/MH/NIMH NIH HHS/United States
- R01 DA012845/DA/NIDA NIH HHS/United States
- U24 MH068457/MH/NIMH NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- K05 AA000145/AA/NIAAA NIH HHS/United States
- R01 AA017535/AA/NIAAA NIH HHS/United States
- R01 AA010249/AA/NIAAA NIH HHS/United States
- G0802736/MRC_/Medical Research Council/United Kingdom
- R00 DA023549/DA/NIDA NIH HHS/United States
- K08 DA019951/DA/NIDA NIH HHS/United States
- R01 DA12690/DA/NIDA NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 AA015416/AA/NIAAA NIH HHS/United States
- R37 AA007728/AA/NIAAA NIH HHS/United States
- MR/L022206/1/MRC_/Medical Research Council/United Kingdom
- R01 AA013320/AA/NIAAA NIH HHS/United States
- P60 DA011015/DA/NIDA NIH HHS/United States
- R01 DA013240/DA/NIDA NIH HHS/United States
- R37 AA012502/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous